Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

  • This share is currently suspended. It was suspended at a price of 0.0026

Share Price Information for Supply@me Cap (SYME)

Share Price is delayed by 15 minutes
Get Live Data
0.0026    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.87m
SYME Live PriceLast checked at - London Stock Exchange

Intraday Supply@me Cap Share Chart

Business update

19 Nov 2025 07:00

RNS Number : 0710I
Supply@ME Capital PLC
19 November 2025
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF UNITED KINGDOM DOMESTIC LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

19 November 2025

 

Supply@ME Capital plc

(the "Company", "Supply@ME" or "SYME" and, together with its subsidiaries, the "Group")

Business update

 

SYME, the fintech business which provides an innovative fintech platform (the "Platform") for use by manufacturing and trading companies to access Inventory Monetisation© ("IM") solutions enabling their businesses to generate cashflow, announces the following business update in respect of the current amount of inventory which has been monetised to date using the Supply@ME Platform through "the first purchase" inventory monetisation transactions.

SYME reported in its Annual Report and Accounts for the year ended 31 December 2024 (the "2024 Annual Report and Accounts") that as at 30 September 2025 the current amount of inventory which had been monetised to date using the Supply@ME Platform through "the first purchase" inventory monetisation transactions was ÂŁ4.5 million. As at the date of this announcement, this figure has increased to ÂŁ7.4 million as a result of the delivery of two new inventory monetisation transactions over the Supply@ME Platform, being one in October 2025 to a new client company from the Group's existing pipeline, and one in November 2025 to an existing client company.

This existing client company is Tekne S.p.A ("Tekne") and in respect of this new inventory monetisation transaction, the independent stock company received funding from Nuburu Inc., a NYSE listed (NYSE American: BURU) high-tech company of which Alessandro Zamboni, a director of the Company, is Executive Chairman ("BURU"), to allow it to purchase the inventory from Tekne. This is in line with the letter of intent that was entered into by BURU and Tekne and which was announced by BURU on 12 November 2025.

In addition to the key performance indicator ("KPI") set out above, the Company resolved to introduce a new KPI to report the amount of inventory which is currently monetised as at 18 November 2025 (being the most practicable date prior to this announcement) using the Supply@ME Platform is ÂŁ5.9 million. This new KPI takes into account those IM transactions which have now come to the end of their contracted period, which is typically three years, and where the inventory that was originally monetised has now been purchased back by the client company from the independent stock company. As such, after the end of the contracted period, the Supply@ME Platform is no longer being utilised. This new KPI is considered important to report from the date of this announcement given that the first IM transaction which was carried out in 2022, has now come to the end of its contracted period.

It should be noted that the two KPI figures outlined in this announcement do not represent the revenue expected to be earned or recognised by the Group.

The Board of Directors consider the IM transactions referred to above, and the associated inventory monetisation fees (as defined in the 2024 Annual Report and Accounts), to be ordinary course of business and concluded on normal market terms.

For the purposes of UK MAR, the person responsible for arranging release of this announcement on behalf of SYME is Alessandro Zamboni, CEO.

Notes

SYME and its operating subsidiaries provide its Platform for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehoused goods waiting to be sold to end-customers or goods that are part of a typical import/export transaction.

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFFWFUAEISEFF
Date   Source Headline
28th Apr 20267:00 amRNSExercise of Open Offer Warrants
27th Apr 20267:00 amRNSDelay in publishing 2025 Annual Financial Report
10th Apr 20267:00 amRNSExercise of Open Offer Warrants
16th Jan 20267:00 amRNSExercise of Open Offer Warrants
6th Jan 20267:00 amRNSProposed acquisition - Heads of Terms
19th Dec 20257:00 amRNSExercise of Open Offer Warrants
19th Dec 20257:00 amRNSExercise of Open Offer Warrants
5th Dec 202511:05 amRNSResults of AGM and Directorate Change
19th Nov 20257:00 amRNSBusiness update
6th Nov 20257:00 amRNSNotice of AGM
23rd Oct 20258:08 amRNSRestoration of Listing and Trading
23rd Oct 20257:30 amRNSRestoration - Supply@Me Capital plc
20th Oct 20257:00 amRNSFunding update
14th Oct 20257:00 amRNSH1 2025 unaudited interim report and accounts
13th Oct 20257:00 amRNS2024 Annual Report and Accounts
29th Sep 20257:00 amRNSDelay in publication of the H12025 interim results
18th Sep 20257:00 amRNSFunding update
15th Sep 20252:32 pmRNSFunding update
1st Sep 20257:00 amRNSFacility Amendment and Funding Update
31st Jul 20257:00 amRNSFunding update
16th Jul 20257:00 amRNSFunding update
2nd Jul 202512:00 pmRNSFunding update
24th Jun 20257:00 amRNSFunding update
11th Jun 20257:00 amRNSFacility Amendment and Funding Update
2nd Jun 20257:00 amRNSFunding Update
6th May 20257:00 amRNSPDMR Resignation
1st May 20257:00 amRNSFunding update
28th Apr 20257:00 amRNSDelay in published 2024 Annual Report and Accounts
1st Apr 202510:58 amRNSFunding update
19th Mar 20257:00 amRNSNew Funding Facility
14th Feb 20257:00 amRNSAppointment of new auditor
10th Feb 20257:00 amRNSFunding update
20th Jan 20257:00 amRNSDirector’s Other External Appointments
17th Dec 20247:00 amRNSBusiness Update
30th Sep 20242:45 pmRNSUnaudited interim results
25th Sep 20247:00 amRNSResignation of Auditor
6th Sep 20247:00 amRNSDirectorate Change
9th Jul 20247:00 amRNSExercise of Open Offer Warrants
28th Jun 20249:22 amRNSResult of AGM
31st May 202411:14 amRNSHolding(s) in Company
31st May 20247:00 amRNSTotal Voting Rights
29th May 20244:58 pmRNSNotice of Annual General Meeting
21st May 20247:00 amRNSStrategic alliance with p-Chip Corporation
15th May 20247:00 amRNSNew equity funding secured for £1,552,500
10th May 202411:47 amRNSPublication of the 2023 Annual Report and Accounts
9th May 20245:02 pmRNSIndependent Auditor's Report
1st May 20247:00 amRNS2023 Annual Report and Accounts
29th Apr 202412:27 pmRNSAgreement signed to launch a IM programme
5th Apr 20247:00 amRNSBusiness update
4th Apr 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.